Abstract

The low biomass of respiratory samples makes it difficult to accurately characterise the microbial community composition. PCR conditions and contaminating microbial DNA can alter the biological profile. The objective of this study was to benchmark the currently available laboratory protocols to accurately analyse the microbial community of low biomass samples. To study the effect of PCR conditions on the microbial community profile, we amplified the 16S rRNA gene of respiratory samples using various bacterial loads and different number of PCR cycles. Libraries were purified by gel electrophoresis or AMPure XP and sequenced by V2 or V3 MiSeq reagent kits by Illumina sequencing. The positive control was diluted in different solvents. PCR conditions had no significant influence on the microbial community profile of low biomass samples. Purification methods and MiSeq reagent kits provided nearly similar microbiota profiles (paired Bray–Curtis dissimilarity median: 0.03 and 0.05, respectively). While profiles of positive controls were significantly influenced by the type of dilution solvent, the theoretical profile of the Zymo mock was most accurately analysed when the Zymo mock was diluted in elution buffer (difference compared to the theoretical Zymo mock: 21.6% for elution buffer, 29.2% for Milli-Q, and 79.6% for DNA/RNA shield). Microbiota profiles of DNA blanks formed a distinct cluster compared to low biomass samples, demonstrating that low biomass samples can accurately be distinguished from DNA blanks. In summary, to accurately characterise the microbial community composition we recommend 1. amplification of the obtained microbial DNA with 30 PCR cycles, 2. purifying amplicon pools by two consecutive AMPure XP steps and 3. sequence the pooled amplicons by V3 MiSeq reagent kit. The benchmarked standardized laboratory workflow presented here ensures comparability of results within and between low biomass microbiome studies.

Details

Title
Benchmarking laboratory processes to characterise low-biomass respiratory microbiota
Author
Raiza, Hasrat 1 ; Kool Jolanda 2 ; de Steenhuijsen Piters Wouter A A 1 ; Chu Mei Ling J N 1 ; Kuiling Sjoerd 2 ; Groot, James A 2 ; van Logchem Elske M 2 ; Fuentes, Susana 2 ; Franz Eelco 2 ; Bogaert Debby 3 ; Bosch Thijs 2 

 Wilhelmina Children’s Hospital/University Medical Center Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118) 
 National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118) 
 Wilhelmina Children’s Hospital/University Medical Center Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118); University of Edinburgh, University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2564325279
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.